Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05871762

Choice of the Optimal Treatment Strategies for Mid-low REctal Cancer

Choice of the Optimal Treatment Strategies for Mid-low REctal Cancer-a National Multi-center, Prospective, Real World Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
3,705 (estimated)
Sponsor
Peking Union Medical College Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare the efficacy, prognosis, health economics of different treatment modalities of mid-low rectal cancer in different centers in China, and to conduct cost utility analysis (CUA) on the treatment process of rectal cancer to explore the best treatment modality that meets the actual need of medical units in each region and at each level. The investigators hope to provide evidence-based medical suggestions for medical quality control of rectal cancer and revision of clinical guidelines, and provides a source of decision making for medical management and medical insurance.

Conditions

Interventions

TypeNameDescription
OTHERRegistry study, no specific interventionRegistry study, no specific intervention

Timeline

Start date
2023-06-04
Primary completion
2027-05-17
Completion
2027-05-17
First posted
2023-05-23
Last updated
2023-08-28

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05871762. Inclusion in this directory is not an endorsement.

Choice of the Optimal Treatment Strategies for Mid-low REctal Cancer (NCT05871762) · Clinical Trials Directory